This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Tenet Healthcare (THC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the most recent trading session, Tenet Healthcare (THC) closed at $81.40, indicating a -0.94% shift from the previous trading day.
Tenet Healthcare (THC) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
In the latest trading session, Tenet Healthcare (THC) closed at $79.36, marking a +0.04% move from the previous day.
Tenet Healthcare (THC) Gains 60% in a Year: More Room to Run?
by Zacks Equity Research
Diversified treatment network, solid patient volumes in the Hospital segment and robust cash flows continue to drive Tenet Healthcare (THC).
Tenet Healthcare (THC) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
Tenet Healthcare (THC) closed at $75.56 in the latest trading session, marking a +0.77% move from the prior day.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems are part of the Zacks Industry Outlook article.
5 Hospital Stocks to Watch Amid Promising Industry Trends
by Kaibalya Pravo Dey
Rising patient volumes and technological advancements for the Zacks Medical-Hospital industry players are major positives. HCA, UHS, THC, ACHC and CYH are poised to gain from improving operating efficiency.
Why Is Tenet (THC) Up 23.8% Since Last Earnings Report?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tenet (THC) to Divest 3 Hospitals to Novant to Reduce Debt
by Zacks Equity Research
Tenet (THC) expects the divestment of the three South Carolina hospitals to fetch around $2.4 billion in cash.
Tenet Healthcare (THC) Q3 Earnings Beat on Solid Ambulatory Care
by Zacks Equity Research
Tenet Healthcare's (THC) Q3 results gain on improved adjusted admissions and higher pricing yield. Management expects adjusted EPS of $5.43-$6.05 for 2023.
Tenet (THC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Tenet (THC) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Tenet Healthcare (THC) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 20% and 1%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Community Health Systems (CYH) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of -106.25% and 1.66%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Tenet Healthcare (THC) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
Tenet Healthcare (THC) concluded the recent trading session at $54.66, signifying a +0.16% move from its prior day's close.
Tenet Healthcare (THC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Tenet Healthcare (THC) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
In the closing of the recent trading day, Tenet Healthcare (THC) stood at $54.13, denoting a +0.07% change from the preceding trading day.
Will Tenet (THC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Tenet (THC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Brookdale's (BKD) September 2023 Occupancy Volumes Increase
by Zacks Equity Research
Brookdale (BKD) has seen a continuous streak of 23 months of year-over-year increases in the weighted average occupancy level.
Ensign (ENSG) Buys Providence Place Nursing Facility in Kansas
by Zacks Equity Research
The Providence Place deal increases Ensign's (ENSG) portfolio to encompass 296 healthcare operations, spanning 13 states.
UnitedHealth (UNH) Arm Optum Partners With ProHealth Care
by Zacks Equity Research
Per the deal, more than 800 employees of ProHealth Care are likely to shift to UnitedHealth's (UNH) Optum business.
Elevance Health (ELV) to Expand in 91 New Counties in 2024
by Zacks Equity Research
Elevance Health (ELV) is set to enhance its product suite and expand to 91 counties in 2024, improving the overall health of people.
Tenet Healthcare (THC) Rides on Strong Patient Volumes, Buyouts
by Zacks Equity Research
Tenet Healthcare (THC) gains from expanding patient admissions, diversified treatment network, acquisitions and robust cash-generating abilities.
Here's Why Hold Strategy is Apt for Teladoc (TDOC) Stock Now
by Zacks Equity Research
Teladoc's (TDOC) BetterHelp business is expected to gain from new member growth and stable customer acquisition costs.
The Joint (JYNT) Forays Into West Virginia Chiropractic Market
by Zacks Equity Research
The Joint's (JYNT) new facility is positioned near the West Virginia University campus, at a high-traffic shopping center.